Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/4171
DC FieldValueLanguage
dc.contributor.authorP., Ciapettien_us
dc.contributor.authorM., Falornien_us
dc.contributor.authorTaddei, Maurizioen_us
dc.date.accessioned2021-03-30T14:42:12Z-
dc.date.available2021-03-30T14:42:12Z-
dc.date.issued1996-
dc.identifier.issn0040-4020en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/4171-
dc.description45960en_US
dc.description.abstractThe addition of gamma-monosubstituted allylchromium(lll) reagents to N-protected alpha-amino aldehydes proceeds in a stereoconvergent manner in contrast with the case of the unsubstituted reagents, where the stereoselectivity depends on the nature of the group bonded to the nitrogen. The chromium(III) reagent derived from 3-chloromethyl-2-trimethylsilyl-1-propene was used to prepare a C-2 symmetric HIV-protease inhibitor. Copyright (C) 1996 Elsevier Science Ltden_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofTETRAHEDRONen_US
dc.titleCrCl2 mediated addition of allylic halides or phosphates to N-protected alpha-amino aldehydes. Stereocontrolled synthesis of a new core for C-2 symmetric HIV-protease inhibitors.en_US
dc.typeArticleen_US
dc.identifier.doi10.1016/0040-4020(96)00258-Xen_US
dc.identifier.scopus2-s2.0-0029970263en_US
dc.identifier.isiWOS:A1996UL79000014en_US
dc.relation.volume52en_US
dc.description.firstpage7379en_US
dc.description.lastpage7390en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
crisitem.author.orcid0000-0001-8660-7580-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.